Kilroy Conor 4
4 · Aura Biosciences, Inc. · Filed Mar 3, 2026
Research Summary
AI-generated summary of this filing
Aura (AURA) CLO Conor Kilroy Receives Equity Awards
What Happened Conor Kilroy, Chief Legal Officer and Secretary of Aura Biosciences (AURA), was granted equity awards on 2026-03-02: 62,339 restricted stock units (RSUs) and 112,661 derivative awards (options/option-like awards). Both grants were recorded at $0.00 (no cash purchase); total awards equal 175,000 underlying shares. These awards are compensation grants rather than open-market purchases or sales.
Key Details
- Transaction date and price: 2026-03-02, acquired at $0.00 per share.
- Award breakdown: 62,339 RSUs (F1) and 112,661 derivative/option-linked awards (F2).
- Vesting:
- RSUs (F1): vest in four substantially equal annual installments beginning January 15, 2027, subject to continued service.
- Derivative/option (F2): 25% vests on February 1, 2027, remainder vests pro rata over the following 36 months, subject to continued service.
- Shares owned after transaction: not specified in the provided filing excerpt.
- Filing timeliness: Report filed 2026-03-03 for a 2026-03-02 transaction (appears timely).
- Role note: Reporting person is Chief Legal Officer and Secretary (per filing remarks).
Context These awards are typical executive compensation grants. RSUs convert to common stock only as they vest; the derivative award vests over time and is subject to service conditions. No shares were sold or purchased on the open market in this filing, and no immediate cashless exercise or sale was reported.
Insider Transaction Report
- Award
Common Stock
[F1]2026-03-02+62,339→ 229,573 total - Award
Stock Option (Right to Buy)
[F2]2026-03-02+112,661→ 112,661 totalExercise: $6.14Exp: 2036-03-02→ Common Stock (112,661 underlying)
Footnotes (2)
- [F1]These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on January 15, 2027, subject to the Reporting Person's continued service as of each such vesting date.
- [F2]The shares underlying this option vest as follows: 25% of the shares vest on February 1, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.